> Bavarian Nordic has earned a $50 million advanced payment for achieving milestones outlined in its contract to provide smallpox vaccine to the U.S. government. Report [1]
> Coley Pharmaceuticals of Wellesley, MA has adopted a shareholder rights program. Release [2]
> Cyclacel Pharmaceuticals has acquired Align Pharmaceuticals for about $3.5 million in cash. Release [3]
> UK-based Shire Pharmaceuticals is selling a block of medicines to Almirall [4] of Spain for $213 million. Report [5]
> A Florida jury ruled for Merck in yet another Vioxx case, bringing the drug maker's record to 11-5 in trials related to the drug. Report [6]
> Eli Lilly is owning up to Zyprexa's ills [7] in new warnings added to the medicine's label. Report [8]
And Finally...Too much debt? Blame it on your genes. New research indicates that our genes may play a key role in our economic behavior. Report [9]
Links:
[1] http://www.forbes.com/afxnewslimited/feeds/afx/2007/10/08/afx4195448.html
[2] http://www.fiercebiotech.com/press-releases/press-release-coley-pharmaceutical-group-adopts-shareholder-rights-plan
[3] http://www.fiercebiotech.com/press-releases/press-release-cyclacel-pharmaceuticals-acquires-align-pharmaceuticals
[4] http://www.fiercebiotech.com/story/almirall-gw-pharma-ink-deal-for-cannabis-based-sativex/2005-12-12
[5] http://www.fiercepharma.com/story/shire-casts-non-core-drugs-213m/2007-10-08
[6] http://www.fiercepharma.com/story/merck-chalks-another-vioxx-victory/2007-10-08
[7] http://www.fiercebiotech.com/story/lilly-ignored-zyprexa-safety-data-on-weight-blood-sugar/2006-12-21
[8] http://www.fiercepharma.com/story/lilly-strengthens-zyprexa-warnings/2007-10-08
[9] http://www.iht.com/articles/2007/10/08/arts/globesci.php